NIH funding profile · Hackensack, NJ · Hospital
Hackensack University Medical Center NIH Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Hackensack University Medical Center received $40.0M in NIH award funding in fiscal year 2026 across 26 award records and 27 principal investigators. That ranks #167 of 2,407 NIH-funded institutions and #4 in New Jersey, up 23.4% from FY2025.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIH funding
$40.0M
+23.4% vs FY2025
National rank
#167
Up 19 places from #186 vs FY2025
Rank in New Jersey
#4
9.0% of New Jersey NIH funding
Awards · PIs
26
27 investigators · 5 new projects
NIH funding trend, FY2022–FY2026
Hackensack University Medical Center received $196.1M in NIH awards over these five fiscal years. Annual funding moved −53.2% from FY2022 to FY2026. Its best national rank in the period was #91 (FY2022).
| Year | Funding | Change | Awards | PIs | U.S. rank | NJ rank | Top IC |
|---|---|---|---|---|---|---|---|
| FY2026 | $40.0M | +23.4% | 26 | 27 | #167 | #4 | NIAID |
| FY2025 | $32.4M | +90.6% | 25 | 23 | #186 | #4 | NIAID |
| FY2024 | $17.0M | −19.1% | 26 | 28 | #252 | #4 | NIAID |
| FY2023 | $21.0M | −75.4% | 26 | 29 | #230 | #4 | NIAID |
| FY2022 | $85.6M | — | 25 | 21 | #91 | #1 | NIAID |
NIH institutes funding Hackensack University Medical Center, FY2026
5 NIH institutes and centers administered awards here in FY2026. The largest, the National Institute of Allergy and Infectious Diseases (NIAID), accounted for 72.7% of the institution's NIH funding across 13 awards.
- NIAID · National Institute of Allergy and Infectious Diseases$29.1M · 72.7%
13 awards · vs FY2025: +28.6%
- OD · NIH Office of the Director$5.2M · 12.9%
2 awards · vs FY2025: +3.0%
- NCI · National Cancer Institute$4.5M · 11.2%
9 awards · vs FY2025: +2.7%
- NIMH · National Institute of Mental Health$818K · 2.0%
1 award · vs FY2025: —
- NHLBI · National Heart, Lung, and Blood Institute$471K · 1.2%
1 award · vs FY2025: —
Award mechanism mix
Share of NIH award dollars by activity-code family in FY2026, with the FY2022 share for comparison. R01-equivalent research grants were 25.7% of funding.
- Cooperative agreements (U)68.7% · FY22 83.9%
- R01-equivalent25.7% · FY22 15.0%
- Other research (R)4.6% · FY22 1.2%
- Career development (K)1.0% · FY22 0.0%
- Contracts (N)0.0% · FY22 0.0%
Top activity codes, FY2026
| Code | Awards | Funding | Share | Average award |
|---|---|---|---|---|
| U19 | 2 | $21.5M | 53.6% | $10.7M |
| R01 | 13 | $9.8M | 24.4% | $751K |
| UH3 | 1 | $5.2M | 12.9% | $5.2M |
| R21 | 4 | $1.4M | 3.4% | $343K |
| U01 | 1 | $862K | 2.2% | $862K |
| R37 | 1 | $539K | 1.3% | $539K |
| R61 | 1 | $471K | 1.2% | $471K |
| K22 | 1 | $194K | 0.5% | $194K |
| K01 | 1 | $192K | 0.5% | $192K |
| N01 | 1 | $3K | 0.0% | $3K |
Largest FY2026 awards
The biggest single award records by FY2026 dollars. Each links to its NIH RePORTER project page.
- Metropolitan AntiViral Drug Accelerator (opens NIH RePORTER)
4U19AI171401-02 · NIAID
$13.9MU19
- Center for accelerated development of drug candidates targeting high threat bacterial infections (opens NIH RePORTER)
5U19AI189168-02 · NIAID
$7.6MU19
- Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO) (opens NIH RePORTER)
5UH3OD035546-04 · OD
$5.2MUH3
- Celiac and inflammatory bowel diseases: functional post-GWAS approach (opens NIH RePORTER)
5R01AI173261-03 · NIAID
$889KR01
- Tissue specific immunity to fungal infections (opens NIH RePORTER)
5R01AI182977-02 · NIAID
$884KR01
- Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease (opens NIH RePORTER)
5R01AI132374-09 · NIAID
$873KR01
Recently started projects
The latest new (Type 1) FY2026 awards by notice date, out of 5 new projects NIH funded here this year.
- Safety and Pharmacodynamics of L-Citrulline for the Treatment of Pulmonary Hypertension (PH) in Preterm Neonates with Severe Bronchopulmonary Dysplasia (BPD-PH) [CToP BPD-PH] (opens NIH RePORTER)
1R61HL185680-01 · NHLBI · Notice Sep 4, 2026
$471KR61
- Peer Coaching for Digital Health Engagement Among Adolescent and Young Adult (AYA) Cancer Survivors (opens NIH RePORTER)
1K01CA308858-01A1 · NCI · Notice Aug 17, 2026
$192KK01
- CLEAR-Lung: Community-Level Effectiveness to Advance Reach in Lung Cancer Screening (opens NIH RePORTER)
1R01CA315494-01 · NCI · Notice Jul 17, 2026
$770KR01
- Identifying Predictive and Prognostic Adipome Biomarkers in Obese TNBC Mice for Targeted Therapy Development (opens NIH RePORTER)
1R21CA309638-01A1 · NCI · Notice Jul 16, 2026
$460KR21
- Myeloid Phagocyte Activation by Commensal-Activated Complement C5aR1 Signaling: Implications for Tumor-Directed Lymphocyte Response (opens NIH RePORTER)
1R21CA293616-01A1 · NCI · Notice Apr 29, 2026
$467KR21
Other NIH-funded institutions in New Jersey
| # | Institution | Funding |
|---|---|---|
| 1 | Rutgers Biomedical and Health SciencesNewark, NJ | $212.1M |
| 2 | Princeton UniversityPrinceton, NJ | $64.6M |
| 3 | Rutgers, The State University of New JerseyPiscataway, NJ | $43.3M |
| 4 | Hackensack University Medical CenterHackensack, NJ | $40.0M |
| 5 | PsychoGenics, Inc.Paramus, NJ | $16.1M |
Nearby in the national ranking
| # | Institution | Funding |
|---|---|---|
| 164 | Columbia University (Morningside)New York, NY | $41.6M |
| 165 | Boston Medical CenterBoston, MA | $41.2M |
| 166 | Family Health InternationalDurham, NC | $40.1M |
| 167 | Hackensack University Medical CenterHackensack, NJ | $40.0M |
| 168 | Cold Spring Harbor LaboratoryCold Spring Harbor, NY | $39.9M |
| 169 | University of Mississippi Medical CenterJackson, MS | $39.5M |
| 170 | University of Tennessee Health Science CenterMemphis, TN | $38.6M |
Similar hospitals and medical centers
| # | Institution | Funding |
|---|---|---|
| 156 | Rhode Island HospitalProvidence, RI | $45.2M |
| 162 | Massachusetts Eye and Ear InfirmaryBoston, MA | $42.0M |
| 165 | Boston Medical CenterBoston, MA | $41.2M |
| 167 | Hackensack University Medical CenterHackensack, NJ | $40.0M |
| 171 | Roswell Park Comprehensive Cancer CenterBuffalo, NY | $38.3M |
| 175 | Lurie Children's Hospital of ChicagoChicago, IL | $37.0M |
| 179 | National Jewish HealthDenver, CO | $36.5M |
About these numbers
Source: the public NIH RePORTER API, refreshed October 16, 2026. See our data methodology and the guide to reading NIH funding rankings by university.
- Who is countedAwards made to NIH recipient organization code 3117901. A university's medical school, affiliated hospital, or other campuses can be separate NIH recipients with their own totals.
- What is countedTotal award amount (direct plus indirect) obligated in each fiscal year for grants, cooperative agreements, training awards, SBIR/STTR, and R&D contracts. Subprojects, intramural research, and interagency agreements are excluded.
- InstitutesEach award is credited in full to its administering institute, even when other institutes co-fund it.
- SubawardsNIH reports the prime recipient only, so research this institution performs under another organization's grant is not included here.